Table 2.
Correlation between the IL-6, CRP and clinicopathological parameters
| IL-6 | CRP | |||||
|---|---|---|---|---|---|---|
| Median ± SD | r | P | Median ± SD | R | P | |
| Total | pg/ml | (mg/dl) | ||||
| Tumor depth | ||||||
| pT1 | 8.1 ± 5.7 | 0.564 | 0.001 | 8.4 ± 3.1 | 0.374 | 0.304 |
| pT2 | 17.8 ± 8.6 | 10.5 ± 2.7 | ||||
| pT3 | 19.2 ± 10.0 | 9.0 ± 2.4 | ||||
| pT4 | 26.2 ± 11.2 | 16.0 ± 3.3 | ||||
| LN meta | ||||||
| N1 | 11.6 ± 4.8 | 0.844 | 0.000 | 9.6 ± 4.1 | 0.690 | 0.000 |
| N2 | 20.7 ± 6.9 | 15.7 ± 9.0 | ||||
| N3 | 32.1 ± 10.7 | 29.4 ± 15.6 | ||||
| Distant meta | ||||||
| Metastasis(-) | 17.3 ±7.6 | 0.773 | 0.009 | 13.9 ± 8.5 | 0.175 | 0.061 |
| Metastasis(+) | 39.7 ± 9.3 | 37.4 ± 16.0 | ||||
| TNM stage | ||||||
| 2A | 5.6 ± 1.5 | 0.702 | 0.000 | 10.1 ± 3.9 | 0.463 | 0.000 |
| 2B | 11.7 ± 4.4 | 9.2 ± 4.6 | ||||
| 3A | 16.9 ± 4.7 | 13.8 ± 7.2 | ||||
| 3B | 19.1 ± 4.8 | 12.8 ± 9.2 | ||||
| 3C | 26.3 ± 7.0 | 21.5 ± 9.9 | ||||
| 4 | 39.8 ± 9.4 | 37.5 ± 16.0 | ||||